Navigation Links
Federal Judge Rejects Tobacco Companies' Effort to Block Key Provisions of New Tobacco Regulation Law

Statement of Campaign for Tobacco-Free Kids, American Cancer Society, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and American Legacy Foundation

WASHINGTON, Nov. 5 /PRNewswire-USNewswire/ -- In a clear victory for public health, a federal judge in Kentucky today rejected a motion by tobacco companies to block key provisions of the new law giving the U.S. Food and Drug Administration (FDA) the power to regulate tobacco products. Specifically, today's decision strongly supports the government's authority to prevent the industry from making health claims about its products without FDA approval.


We applaud the federal court's decision to quickly and decisively reject the latest attempt by Big Tobacco to frustrate the intent of the new FDA law and allow the agency to get on with its role in putting an end to deceptive and dangerous tobacco marketing.

Eleven public health and consumer advocacy groups joined in the legal effort to thwart the industry's challenge to the law based on the claim that its First Amendment rights were violated. U.S. District Court Judge Joseph H. McKinley denied a request from R.J. Reynolds and other tobacco companies to keep the FDA from implementing the law, saying they have "little likelihood" in proving that their free speech rights have been harmed. Judge McKinley forcefully backed the government's interest in protecting consumers from misleading claims about tobacco products with supposedly reduced health risks.

The judge agreed with the key argument that "given the significant health risks associated with the use of tobacco products and the history of marketing 'low tar' and 'light' cigarettes," the government "has a substantial interest in protecting consumers from misleading tobacco industry claims about allegedly reduced risk tobacco products."

The court's ruling supports the portion of the FDA law that requires tobacco companies to submit for the agency's review any claims of reduced risk. The FDA is empowered to determine if the claim is scientifically justified and benefits public health. McKinley cited a pivotal ruling in the Department of Justice's racketeering lawsuit against the tobacco companies, noting that tobacco companies have a "history of advancing their bottom line by misleading consumers about the health risks associated with their products."

The groups who joined the government in supporting the FDA law are: The Campaign for Tobacco-Free Kids, American Cancer Society, American Cancer Society Cancer Action Network, American Heart Association, American Legacy Foundation, American Lung Association, American Medical Association, American Public Health Association, Kentucky Medical Association, Oncology Nursing Society and Public Citizen.

Tobacco use is the leading preventable cause of death in the United States, killing more than 400,000 people and costing $96 billion in health care costs annually.

SOURCE Campaign for Tobacco-Free Kids

SOURCE Campaign for Tobacco-Free Kids
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Federal stimulus funds support studies geared to improving HIV care and prevention
2. School Violence Drops With Federal Program
3. MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
4. Cardiac Patients Across Rural America Risk Losing Access to Nearby Care as Federal Agency Considers Cuts this Week
5. Bolton School of Nursing at CWRU receives $3.7 million in federal stimulus funding
6. Judge Halts IHSS Home Care Cuts; Says They Likely Violate Federal Law
7. IPRO Wins Federal Contract to Support Hospice Oversight
8. Homecare Recipients and Providers to Rally against Cuts in IHSS Program; Hearing on Lawsuit in Oakland Federal Court Monday
9. Department of Public Welfare Earns Federal Recognition for Programs and Services for Children
10. NeuroAIDS is Target of Federal Grant to Childrens Hospital
11. Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
Post Your Comments:
(Date:11/25/2015)... ... ... Dr. John Pierce, Medical Director at the Ageless Forever clinic in Las ... Pro laser therapy cap. FDA cleared for safety and efficacy, the Capillus272 offers men ... surgery, prescription pills, or topical foams. , “Capillus272™ Pro is a home-use device ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, ... Two Organizations, One Beat ” campaign. The partnership between the two groups began in ... in MAP International’s cause. , MAP International was founded in 1954 and is an ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would ... OH , are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE ... Cleveland, OH. , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli ...
(Date:11/25/2015)... ... 25, 2015 , ... The McHenry County law firm of Botto Gilbert ... Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the ... App (2d) 130884WC. , According to court documents, Adcock testified that on May 10, ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) ... plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion of ... Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for his ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
(Date:11/25/2015)... Kitov Pharma ceuticals ... biopharmaceutical company focused on the development of therapeutic candidates ... announced the closing of its previously announced underwritten public ... each representing 20 ordinary shares of the Company, and ... and warrants were issued in a fixed combination of ...
(Date:11/25/2015)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer of ... Antonius Schuh, Ph.D., is scheduled to present a corporate ... Healthcare Conference. th Annual Piper Jaffray ... New York on Tuesday, December ... be available for one-on-one meetings during the conference. The ...
Breaking Medicine Technology: